Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical, a pathology solutions business, in an all-cash transaction valued at $950 million. Agilent aims to ...

Agilent Technologies acquires Biocare Medical for $950M to expand into high-growth pathology and cancer diagnostics, enhancing recurring consumables revenue streams. Agilent trades below historical ...

Biocare will become part of Agilent Life Sciences and Diagnostics Markets Group Biocare generated over $90 million in revenue in 2025 Agilent generated revenue of $6.95 billion in fiscal year 2025 ...

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Agilent Technologies Inc. agreed to acquire privately held Biocare Medical, which makes instruments and materials used in cancer research, in an all-cash transaction valued at $950 million. Biocare ...

Agilent to acquire Biocare Medical in $950 million all-cash deal Life sciences firm Agilent Technologies said on Monday that it will acquire privately held clinical pathology firm Biocare Medical in ...

BIOCARE Lifesciences Inc. inaugurated its new corporate office at Centuria Medical Makati on Feb. 24–25, 2026, marking a new phase of growth for the company and further strengthening health care ...

Agilent Technologies Inc. has agreed to buy Biocare Medical LLC for $950 million in cash in a bid to strengthen its pathology portfolio. The deal adds Biocare’s complementary immunohistochemistry ...

We've read the fine print -- and consulted experts -- about Apple's irregular heart rhythm technology so you don’t have to. Danielle Kosecki is an award-winning journalist who has covered health and ...

Almost five months after being selected for the DBT Biocare programme, an initiative by the Department of Biotechnology (DBT) to encourage women scientists, none of the 75 chosen candidates has ...